Literature DB >> 30217288

Pancreatoduodenectomy for pancreatic head tumors in the elderly - Systematic review and meta-analysis.

Michał Pędziwiatr1, Piotr Małczak2, Magdalena Mizera3, Jan Witowski3, Grzegorz Torbicz3, Piotr Major2, Magdalena Pisarska2, Michał Wysocki2, Miłosz Jankowski4, Mateusz Rubinkiewicz3, Anna Lasek3, Jan Kulawik3, Andrzej Budzyński2.   

Abstract

The age at which patients are undergoing pancreatoduodenectomy is increasing worldwide. The data on the outcome of this surgical procedure in the elderly is constantly expanding. This meta-analysis aims to assess the safety of pancreatoduodenectomy in elderly population, primarily focusing on morbidity and mortality. We searched the Medline, Embase and Cochrane databases to identify eligible studies. The most recent search was performed on 10th April 2017. Inclusion criteria were: (1) comparison of the characteristics and perioperative outcomes of older patients versus younger patients undergoing pancreatoduodenectomy; (2) objective evaluation of mortality or overall morbidity; and (3), publication in English. Exclusion criteria were: (1) a lack of comparative data; (2) a lack of primary outcomes or insufficient data to analyze; (3) a focus on procedures other than pancreatoduodenectomy; or (4), the impossibility of extraction of data specifically concerning pancreatoduodenectomy. Primary outcomes were overall morbidity and mortality. Secondary outcomes analyzed postoperative complications, R0 rate and length of hospital stay. 45 eligible studies were chosen, with a combined total of 21,295 patients. Older patients compared to younger patients had a higher risk of death (2.26% vs. 4.54%; RR: 2.23; 95% CI 1.74-2.87) and a higher complication rate (47.23% vs. 39.35%; RR: 1.17; 95% CI 1.12-1.24). There were no differences in pancreatic fistula occurrence (p = 0.27), bile leakage (p = 0.81), postoperative hemorrhage (p = 0.08), or R0 rate (p = 0.92). Our review confirms, that in the case of pancreatoduodenectomy, advanced age is a risk factor for increased non-surgical morbidity and, by extension, higher mortality.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Elderly; Octogenarians; Pancreatic resection; Whipple; meta-Analysis

Mesh:

Year:  2018        PMID: 30217288     DOI: 10.1016/j.suronc.2018.05.021

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  5 in total

1.  Laparoscopic versus open liver resections of posterolateral liver segments - a systematic review and meta-analysis.

Authors:  Mateusz Rubinkiewicz; Magdalena Mizera; Piotr Małczak; Natalia Gajewska; Grzegorz Torbicz; Michael Su; Konrad Karcz; Michał Pędziwiatr
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-04-07       Impact factor: 1.195

2.  Does Major Pancreatic Surgery Have Utility in Nonagenarians with Pancreas Cancer?

Authors:  Rebecca S Meltzer; David A Kooby; Jeffrey M Switchenko; Jashodeep Datta; Darren R Carpizo; Shishir K Maithel; Mihir M Shah
Journal:  Ann Surg Oncol       Date:  2020-11-03       Impact factor: 5.344

3.  Immediate and Long-Term Health Care Support Needs of Older Adults Undergoing Cancer Surgery: A Population-Based Analysis of Postoperative Homecare Utilization.

Authors:  Tyler R Chesney; Barbara Haas; Natalie G Coburn; Alyson L Mahar; Victoria Zuk; Haoyu Zhao; Amy T Hsu; Julie Hallet
Journal:  Ann Surg Oncol       Date:  2020-08-12       Impact factor: 5.344

4.  Pancreaticoduodenectomy as a feasible choice for periampullary malignancy in octogenarians.

Authors:  Stavros Parasyris; Ioannis Hatzaras; Vasiliki Ntella; Theodoros Sidiropoulos; Ioannis Margaris; Nikos Pantazis; Panagiotis Kokoropoulos; Panteleimon Vassiliu; Paraskevi Matsota; Vasileios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Mol Clin Oncol       Date:  2022-08-17

5.  Preoperative Risk Score for Early Mortality After Up-Front Pancreatic Cancer Surgery: A Nationwide Cohort Study.

Authors:  Paulina Bereza-Carlson; Johan Nilsson; Bodil Andersson
Journal:  World J Surg       Date:  2022-08-08       Impact factor: 3.282

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.